Roivant Sciences Pre-Tax Income decreased by 82.6% to -$290.37M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 23.8%, from -$234.51M to -$290.37M. Over 2 years (FY 2021 to FY 2024), Pre-Tax Income shows an upward trend with a -14.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher values indicate stronger overall profitability and operational efficiency before tax impacts.
Measures the profitability of the company after all operating and non-operating expenses have been deducted, but before...
A standard GAAP metric used universally to compare pre-tax performance across different industries.
income_before_tax| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$100.99M | -$225.24M | -$306.05M | -$291.48M | -$349.79M | -$313.76M | -$382.08M | -$326.09M | -$241.41M | $5.15B | $0.00 | -$19.64M | -$224.38M | -$234.51M | -$203.05M | -$269.26M | -$159.04M | -$290.37M |
| QoQ Change | — | -123.0% | -35.9% | +4.8% | -20.0% | +10.3% | -21.8% | +14.7% | +26.0% | >999% | -100.0% | — | <-999% | -4.5% | +13.4% | -32.6% | +40.9% | -82.6% |
| YoY Change | — | — | — | — | -246.4% | -39.3% | -24.8% | +6.8% | +23.1% | >999% | — | +94.0% | +7.1% | -104.6% | — | <-999% | +29.1% | -23.8% |
| Segment | FY'23 | FY'24 | FY'25 |
|---|---|---|---|
| Other | $584.00K | $241.00K | $5.85M |
| Total | $4.59B | -$681.59M | — |
All segment values are derived from annual filings.